scholarly journals Randomized controlled clinical trial for comparison of peri-implant marginal bone level around SLA and CaP coated SLA surface implants

2018 ◽  
Vol 29 ◽  
pp. 379-379
Author(s):  
Kyunga Ko ◽  
Ui Won Jung ◽  
Seong Ho Choi ◽  
Seung Min Kim ◽  
Jung Seok Lee
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled ◽  
Bone Level ◽  
Marginal Bone Level

scholarly journals Marginal bone level and survival of short and standard-length implants after 3 years: An Open Multi-Center Randomized Controlled Clinical Trial

2018 ◽  
Vol 29 (8) ◽  
pp. 894-906 ◽  
Author(s):  
Homayoun H. Zadeh ◽  
Felix Guljé ◽  
Paul J. Palmer ◽  
Ingemar Abrahamsson ◽  
Stephen Chen ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Standard Length ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled ◽  
Bone Level ◽  
Marginal Bone Level

scholarly journals Treatment of Periimplantitis with Electrolytic Cleaning versus Mechanical and Electrolytic Cleaning: 18-Month Results from a Randomized Controlled Clinical Trial

2021 ◽  
Vol 10 (16) ◽  
pp. 3475
Author(s):  
Markus Schlee ◽  
Hom-Lay Wang ◽  
Thomas Stumpf ◽  
Urs Brodbeck ◽  
Dieter Bosshardt ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Clinical Parameters ◽  
Regenerative Therapy ◽  
Randomized Controlled Clinical Trial ◽  
Pocket Depth ◽  
Randomized Controlled ◽  
Probing Pocket Depth ◽  
Bone Level ◽  
The Mean

Aim of the study: This RCT assesses patients’ 18-month clinical outcomes after the regenerative therapy of periimplantitis lesions using either an electrolytic method (EC) to remove biofilms or a combination of powder spray and an electrolytic method (PEC). Materials and Methods: Twenty-four patients (24 implants) suffering from periimplantitis were randomly treated by EC or PEC followed by augmentation and submerged healing. Probing pocket depth (PPD), Bleeding on Probing (BoP), suppuration, and standardized radiographs were assessed before surgery (T0), 6 months after augmentation (T1), and 6 (T2) and 12 (T3) months after the replacement of the restoration. Results: The mean PPD changed from 5.8 ± 1.6 mm (T0) to 3.1 ± 1.4 mm (T3). While BoP and suppuration at T0 were 100%, BoP decreased at T2 to 36.8% and at T3 to 35.3%. Suppuration was found to be at a level of 10.6% at T2 and 11.8% at T3. The radiologic bone level measured from the implant shoulder to the first visible bone to the implant contact was 4.9 ± 1.9 mm at mesial sites and 4.4 ± 2.2 mm at distal sites at T0 and 1.7 ± 1.7 mm and 1.5 ± 17 mm at T3. Conclusions: Significant radiographic bone fill and the improvement of clinical parameters were demonstrated 18 months after therapy.

scholarly journals Treatment of Periimplantitis - Electrolytic Cleaning versus Mechanical and Electrolytic Cleaning - A Randomized Controlled Clinical Trial – 18 Months Results

2021 ◽  
Author(s):  
Markus Schlee ◽  
Hom-Lay Wang ◽  
Thomas Stumpf ◽  
Urs Brodbeck ◽  
Florian Rathe
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Clinical Parameters ◽  
Regenerative Therapy ◽  
Randomized Controlled Clinical Trial ◽  
Pocket Depth ◽  
Randomized Controlled ◽  
Probing Pocket Depth ◽  
Bone Level ◽  
Bone To Implant Contact

Background: this RCT assesses the 18 months clinical outcomes after regenerative therapy of periimplantitis lesions using either an electrolytic method (EC) to remove biofilms or a combination of powder spray and electrolytic method (PEC). Materials and Methods: Twenty-four patients (24 implants) suffering from periimplantitis were randomly treated by EC or PEC followed by augmentation and submerged healing. Probing pocket depth (PPD), Bleeding on Probing (BoP), suppuration and standardized radiographs were assessed before surgery (T0), 6 months after augmentation (T1), 6 (T2) and 12 (T3) months after replacement of the restoration. Results: Mean of PPD changed from 5.8 ± 1.6 mm (T0) to 3.1 ± 1.4 mm (T3). While BoP and suppuration at T0 was 100 % BoP decreased at T2 to 36.8 % and at T3 to 35.3 %. Suppuration could be found 10.6% at T2 and 11.8% at T3. Radiologic bone level measured from the implant shoulder to the first visible bone to implant contact was 4.9 ± 1.9 mm at me-sial and 4.4 ± 2.2 mm at distal sites (T0) and 1.7 ± 1.7 mm and 1.5 ± 17 mm at T3. Conclusions: Significant radiographic bone fill and improvement of clinical parameters were demonstrated 18 months after therapy.

Sign in / Sign up

Export Citation Format

Share Document